{60 (lenvatinib 10 MG Oral Capsule [Lenvima]) / 30 (lenvatinib 4 MG Oral Capsule [Lenvima]) } Pack [Lenvima 24]

RxCUI: 1604352
RxNorm name: {60 (lenvatinib 10 MG Oral Capsule [Lenvima]) / 30 (lenvatinib 4 MG Oral Capsule [Lenvima]) } Pack [Lenvima 24]
Display name: {60 (lenvatinib 10 MG Oral Capsule [Lenvima]) / 30 (lenvatinib 4 MG Oral Capsule [Lenvima]) } Pack [Lenvima 24]
Full name: {60 (lenvatinib 10 MG Oral Capsule [Lenvima]) / 30 (lenvatinib 4 MG Oral Capsule [Lenvima]) } Pack [Lenvima 24]
Term type: BPCK
Status: DailyMed mapping
Updated: 2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lenvima	LENVATINIB	Eisai Inc.	f4bedd21-efde-44c6-9d9c-b48b78d7ed1e	2026-06-30	Warnings, Adverse reactions	Exact identifier rxcui: 1604352

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
f4bedd21-efde-44c6-9d9c-b48b78d7ed1e	{60 (lenvatinib 10 MG Oral Capsule [Lenvima]) / 30 (lenvatinib 4 MG Oral Capsule [Lenvima]) } Pack [Lenvima 24] [BPCK] · Lenvima 24 MG daily dose 30 Day Supply Pack [PSN] · Lenvima 24 MG (as lenvatinib mesylate) Daily Dose 30 Day Supply Pack [SY] · Lenvima 24 MG Daily Dose 30 Day Supply Pack [SY]	4	78	These highlights do not include all the information needed to use LENVIMA safely and effectively. See full prescribing information for LENVIMA . LENVIMA ® ( lenvatinib ) capsules , for oral use Initial U.S. Approval: 2015	20250103